Is McKesson Corporation Stock Outperforming the S&P 500?

McKesson Corporation (MCK), rooted in 1833, has transformed from a modest drug importer into a formidable global healthcare services force. Based in Irving, Texas, it now commands a vast distribution network spanning pharmaceuticals, medical-surgical supplies, and advanced technology solutions for hospitals, pharmacies, and major health systems. Its scale, logistical strength, and deep integration across the healthcare supply chain position McKesson as an indispensable pillar of modern medical infrastructure. Its market capitalization stands at $109.1 billion.

McKesson’s sheer scale secures its “large-cap” status effortlessly, easily surpassing the $10 billion benchmark without breaking a sweat. This size represents decades of built infrastructure, deep distributor relationships, and diversified revenue lines that shield it from volatility in any one business segment. McKesson is big and entrenched, essential, and fully embedded in how the U.S. healthcare system moves, stores, and delivers medicine. Its distribution network alone spans thousands of facilities, making it one of the few players capable of handling high-volume pharmaceutical demand at a national scale.